RNA-DNA polymerase inhibitor, Mithramycin A, Purity ≥98%

Cat. No.: X24-08-YM135

RNA-DNA polymerase inhibitor, Mithramycin A, Purity ≥98%

Synonym: 18378-89-7; Mitramycin; Aureolic acid; Plicamycin; (2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4,5-Dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one

  • CAS Number: 18378-89-7
  • Compound CID: 163659
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Mithramycin A is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting RNA-DNA polymerase.
Molecular Weight
1085.15
Molecular Formula
C52H76O24
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Mithramycin A is a DNA damage inhibitor that can be used for its anti-cancer properties.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.